- 30 November 2011
Ataluren extension trial for Duchenne about to start PTC Therapeutics has affirmed their commitment to develop ataluren to treat boys with Duchenne muscular dystrophy and announced progress in starting an extension trial in the UK, Europe, Israel and Australia.
- 29 November 2011
Collaboration offers new hope for potential spinal muscular atrophy treatment Roche has signed a multi-million dollar agreement with PTC Therapeutics to develop drugs for spinal muscular atrophy
- 28 November 2011
New advances in FSHD research Highlights from the FSH Society meeting in Boston including new insights into the cause of facioscapulohumeral muscular dystrophy and a new diagnostic test for FSHD type 2
- 23 November 2011
Reliable muscle function test for boys with Duchenne developed The Muscular Dystrophy Campaign's North Star project has developed a way to reliably test the muscle function of boys with Duchenne muscular dystrophy.
- 16 November 2011
Combining two exon skipping drugs to treat Duchenne muscular dystrophy A recent scientific publication shows that it may be possible to combine different “exon-skipping” molecular patches into an effective treatment package for Duchenne muscular dystrophy.
- 15 November 2011
AVI Biopharma collaborates to develop new exon skipping drugs for Duchenne AVI Biopharma has entered into collaborations with various research institutions and funding bodies in the US to develop two new exon skipping drugs for Duchenne muscular dystrophy.
- 10 November 2011
Highlights from the World Muscle Society Congress Our Director of Research, Dr Marita Pohlschmidt and Head of Grants, Dr Julia Ambler, attended the World Muscle Society congress and here they summarise their highlights.
- 26 October 2011
National Conference 2011 - research workshop Highlights from the research workshop at the National Conference 2011 where scientists discussed their research projects.
- 26 October 2011
Patient friendly clinical trials resource launched The Muscular Dystrophy Campaign has launched a unique resource for patients and their families to keep up-to-date with the clinical trials for their condition.
- 21 October 2011
Our research communication service praised The Muscular Dystrophy Campaign has been recognised for producing easy-to-understand information relating to medical research for the public